A potential new Alzheimer's drug represses the harmful inflammatory response of the brain's immune cells, reducing disease pathology, preserving neurons and improving cognition in preclinical tests.
from Latest Science News -- ScienceDaily https://ift.tt/9m08jV3
0 Comments